Biocept Inc reports results for the quarter ended in March - Earnings Summary

Biocept

23/05/2022 22:44

* Biocept Inc  BIOC.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 14
cents per share.
    * Revenue rose 12.3% to $19.95 million from a year ago; 
analysts
expected $11.49 million. 
    * Biocept Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * The mean earnings estimate of analysts had fallen by
about 250%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biocept Inc shares had fallen by 37.9% this quarter and
lost 60.2% so far this year.
    * The company reported a quarterly loss of $2.77 million.
    * Wall Street's median 12-month price target for Biocept Inc
is
$9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 23 at 09:44 p.m.  ​All
figures in US dollars unless otherwise stated